FMR1 and fragile X syndrome: The study identified five PM carriers and three women with a full mutation, and suggested that implementation of carrier screening during prenatal diagnosis may provide information about early intervention for those who have the FMR1 mutation, and information on the risk of having a child with FXS in the following pregnancies.